Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/138069
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Should we continue to subsidise therapeutics with uncertain efficacy? Health economic implications for icosapent ethyl |
| Author: | Morton, J. Liew, D. Nicholls, S.J. Ademi, Z. |
| Citation: | European Journal of Preventive Cardiology, 2023; 30(17):1935-1938 |
| Publisher: | Oxford University Press |
| Issue Date: | 2023 |
| ISSN: | 2047-4873 2047-4881 |
| Statement of Responsibility: | Jedidiah I. Morton, Danny Liew, Stephen J. Nicholls, and Zanfina Ademi |
| Keywords: | Humans Cardiovascular Diseases Hypertriglyceridemia Eicosapentaenoic Acid Triglycerides Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| Description: | Published: 20 September 2022 |
| Rights: | © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com. |
| DOI: | 10.1093/eurjpc/zwac212 |
| Grant ID: | http://purl.org/au-research/grants/nhmrc/2012582 |
| Published version: | http://dx.doi.org/10.1093/eurjpc/zwac212 |
| Appears in Collections: | Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.